Cargando…
Cost Resulting from Anti-Tuberculosis Drug Shortages in the United States: A Hypothetical Cohort Study
BACKGROUND: From 2012 through 2014, the United States experienced acute shortages and price escalations of several first-line anti-tuberculosis (TB) medications. Because secondary TB drug regimens are longer and adverse events occur more frequently with them, we sought to conservatively estimate the...
Autores principales: | Scott, James C., Shah, Neha, Porco, Travis, Flood, Jennifer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540488/ https://www.ncbi.nlm.nih.gov/pubmed/26284924 http://dx.doi.org/10.1371/journal.pone.0134597 |
Ejemplares similares
-
Correction: Cost Resulting from Anti-Tuberculosis Drug Shortages in the United States: A Hypothetical Cohort Study
por: Scott, James C., et al.
Publicado: (2015) -
Impact of a Shortage of First-Line Antituberculosis Medication on Tuberculosis Control — United States, 2012–2013
por: Warkentin, Jon, et al.
Publicado: (2013) -
Cost-effectiveness of tuberculosis evaluation and treatment of newly-arrived immigrants
por: Porco, Travis C, et al.
Publicado: (2006) -
Assessing the validity of tuberculosis surveillance data in California
por: Sprinson, Joan E, et al.
Publicado: (2006) -
Physician workforce in the United States of America: forecasting nationwide shortages
por: Zhang, Xiaoming, et al.
Publicado: (2020)